Spain Antidiabetics Industry Outlook 2024 - 2028

See how Spain Antidiabetics performed compared to key markets.

Key Market Indicators

Spanish Insulin Imports are forecasted to climb to $244 million by 2028, up from $236 million in 2023. This represents an average annual growth rate of 0.4%. Since 1994, demand for insulin in Spain has grown at a modest yearly rate of 0.2%. On the export front, Spanish Insulin Exports are projected to surge to $46 million by 2028, a significant increase from $38 million in 2023. This marks an average annual growth rate of 2.8%. Since 1994, the supply of insulin from Spain has seen a robust yearly increase of 9.2%. In 2023, Spain ranked 12th in global insulin exports, with the United Arab Emirates surpassing it at $38 million. The top spots were held by France, Italy, and China, placing 2nd, 3rd, and 4th respectively.

Spain Antidiabetics Market Data and Forecasts

Spain Antidiabetics : how will it grow in the coming years?

Forecast: Diabetes Medicine Sales in Spain
Forecast: Insulin in Dosage Market Size Value in Spain
Forecast: Import of Insulin in Dosage Forms to Spain
Forecast: Export of Insulin in Dosage Forms from Spain
View More

Other Top Countries about Antidiabetics